We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

What Are Biologics? A Comparative Legislative, Regulatory and Scientific Analysis

01 June 2007

Food and Drug Law Journal, Vol. 62, No. 2
Biologics are often described as vaccines, blood products (including blood) and allergenics. Since the late 1940s, however, the types of products that are biologics have been expanding. The advent of modern biotechnology methods in the last 25 years has contributed dramatically to this expansion. Hybridoma and recombinant DNA methods, gene and cellular therapies, and newer technologies, such as the cloning method involved in the creation of Dolly the Sheep in 1996, have challenged traditional notions of what are biologics. The new technologies also have recently resulted in questions of by whom and how biologics should be regulated vis-à-vis other drugs handled by the Center for Drug Evaluation and Research (CDER) or the Center for Veterinary Medicine (CVM).
Loading data